Atkins D - Search Results

1

Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?

Atkins D, Ferrone S, Schmahl GE, Störkel S, Seliger B. Atkins D, et al. J Urol. 2004 Feb;171(2 Pt 1):885-9. doi: 10.1097/01.ju.0000094807.95420.fe. J Urol. 2004. PMID: 14713847

2

Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.

Seliger B, Atkins D, Bock M, Ritz U, Ferrone S, Huber C, Störkel S. Seliger B, et al. Among authors: atkins d. Clin Cancer Res. 2003 May;9(5):1721-7. Clin Cancer Res. 2003. PMID: 12738726

3

MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.

Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, Störkel S, Seliger B. Atkins D, et al. Int J Cancer. 2004 Mar 20;109(2):265-73. doi: 10.1002/ijc.11681. Int J Cancer. 2004. PMID: 14750179

4

Heat shock proteins in renal cell carcinomas.

Atkins D, Lichtenfels R, Seliger B. Atkins D, et al. Contrib Nephrol. 2005;148:35-56. doi: 10.1159/000086042. Contrib Nephrol. 2005. PMID: 15912026 Review.

5

Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy.

Seliger B, Menig M, Lichtenfels R, Atkins D, Bukur J, Halder TM, Kersten M, Harder A, Ackermann A, Beck J, Muehlenweg B, Brenner W, Melchior S, Kellner R, Lottspeich F. Seliger B, et al. Among authors: atkins d. Proteomics. 2003 Jun;3(6):979-90. doi: 10.1002/pmic.200300404. Proteomics. 2003. PMID: 12833523

6

Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma.

Seliger B, Lichtenfels R, Atkins D, Bukur J, Halder T, Kersten M, Harder A, Ackermann A, Malenica B, Brenner W, Zobawa M, Lottspeich F. Seliger B, et al. Among authors: atkins d. Proteomics. 2005 Jul;5(10):2631-40. doi: 10.1002/pmic.200401264. Proteomics. 2005. PMID: 15892167

7

Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses.

Lichtenfels R, Kellner R, Atkins D, Bukur J, Ackermann A, Beck J, Brenner W, Melchior S, Seliger B. Lichtenfels R, et al. Among authors: atkins d. Biochim Biophys Acta. 2003 Mar 21;1646(1-2):21-31. doi: 10.1016/s1570-9639(02)00547-2. Biochim Biophys Acta. 2003. PMID: 12637008

8

HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.

Seliger B, Rongcun Y, Atkins D, Hammers S, Huber C, Störkel S, Kiessling R. Seliger B, et al. Among authors: atkins d. Int J Cancer. 2000 Aug 1;87(3):349-59. Int J Cancer. 2000. PMID: 10897039

9

Concomitant deregulation of HIF1alpha and cell cycle proteins in VHL-mutated renal cell carcinomas.

Atkins DJ, Gingert C, Justenhoven C, Schmahl GE, Bonato MS, Brauch H, Störkel S. Atkins DJ, et al. Virchows Arch. 2005 Sep;447(3):634-42. doi: 10.1007/s00428-005-1262-y. Epub 2005 Jul 1. Virchows Arch. 2005. PMID: 15991006

10

Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival.

Lou Y, Vitalis TZ, Basha G, Cai B, Chen SS, Choi KB, Jeffries AP, Elliott WM, Atkins D, Seliger B, Jefferies WA. Lou Y, et al. Among authors: atkins d. Cancer Res. 2005 Sep 1;65(17):7926-33. doi: 10.1158/0008-5472.CAN-04-3977. Cancer Res. 2005. PMID: 16140964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

891 results

Search Page

Filters